Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00180479
Show Display Options
Download search resultsDownload the search results for:
NCT00180479 (1 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed
Has Results
SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)
Conditions: Stents;   Coronary Artery Disease;   Total Coronary Occlusion;   Coronary Artery Restenosis;   Stent Thrombosis;   Vascular Disease;   Myocardial Ischemia;   Coronary Artery Stenosis
Interventions: Device: XIENCE V® Everolimus Eluting Coronary Stent;   Device: TAXUS® EXPRESS2™ Paclitaxel Eluting Coronary Stent

Indicates status has not been verified in more than two years